Pharmacological Research
Epalrestat reduced bone loss in mouse disease models
Early-intervention experiments tested the drug in mice with diabetes or bone loss induced by ovary removal or inflammation.Early-intervention experiments tested the drug in mice with diabetes or bone loss induced by ovary removal or inflammation.
Mouse studyBones and joints
Who was studiedMice with diabetes or induced bone loss
What changedEpalrestat reduced bone loss in mice with diabetes or bone loss induced by ovary removal or inflammation
The catchThe experiments addressed early intervention, not treatment of established bone loss